Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4164)
All Articles published online
|
Dec 28, 2011 (publication date) through Jun 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hsieh PS, Hsieh YJ. Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 2011; 17(48): 5240-5245 [PMID: 22219592 DOI: 10.3748/wjg.v17.i48.5240] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i48/5240.htm |
| Number | Citing Articles |
| 1 |
Carmen Andrea Pfortmueller, Christoph Wiemann, Georg-Christian Funk, Alexander Benedikt Leichtle, Georg Martin Fiedler, Aristomenis Konstantinos Exadaktylos, Gregor Lindner. Hypoglycemia is associated with increased mortality in patients with acute decompensated liver cirrhosis. Journal of Critical Care 2014; 29(2): 316.e7 doi: 10.1016/j.jcrc.2013.11.002
|
| 2 |
Thaïs Rouquet, Marion S Bonnet, Clément Pierre, Michel Dallaporta, Jean-Denis Troadec, Julien Roux, Bruno Bariohay. The Central Question of Type 2 Diabetes. Pharmaceutical Patent Analyst 2013; 2(3): 399 doi: 10.4155/ppa.13.22
|
| 3 |
Wen-You Zhang, Huan-Huan Zhang, Chen-Huan Yu, Jie Fang, Hua-Zhong Ying. Ethanol extract of Atractylodis macrocephalae Rhizoma ameliorates insulin resistance and gut microbiota in type 2 diabetic db/db mice. Journal of Functional Foods 2017; 39: 139 doi: 10.1016/j.jff.2017.10.020
|
| 4 |
Xuling Liu, Zuxin Liang, Hongwei Duan, Jianhai Yu, Zhiran Qin, Jingshu Li, Li Zhu, Qinghua Wu, Weiwei Xiao, Chenguang Shen, Chengsong Wan, Kefeng Wu, Hua Ye, Bao Zhang, Wei Zhao. Dengue virus is involved in insulin resistance via the downregulation of IRS-1 by inducing TNF-α secretion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(10): 166472 doi: 10.1016/j.bbadis.2022.166472
|
| 5 |
C. H. Jung, W. J. Lee, J. Y. Hwang, J. H. Yu, M. S. Shin, M. J. Lee, J. E. Jang, J. Leem, J.‐Y. Park, H.‐K. Kim. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. Diabetic Medicine 2013; 30(4): 428 doi: 10.1111/dme.12104
|
| 6 |
Vladislav Volarevic, Maja Misirkic, Ljubica Vucicevic, Verica Paunovic, Bojana Simovic Markovic, Maja Stojanovic, Marija Milovanovic, Vladimir Jakovljevic, Dragan Micic, Nebojsa Arsenijevic, Vladimir Trajkovic, Miodrag L. Lukic. Metformin aggravates immune-mediated liver injury in mice. Archives of Toxicology 2015; 89(3): 437 doi: 10.1007/s00204-014-1263-1
|
| 7 |
Yuanyuan Li, Ying Zhao, Jianping Wu, Ferruccio Bonino. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis. PLOS ONE 2017; 12(5): e0177713 doi: 10.1371/journal.pone.0177713
|
| 8 |
Marleen M.J. van Greevenbroek, Casper G. Schalkwijk, Coen D.A. Stehouwer. Inflammation - From Molecular and Cellular Mechanisms to the Clinic. 2017; : 1225 doi: 10.1002/9783527692156.ch47
|
| 9 |
Ye Zhang, Jiaojiao Huang, Sanshan Xia, Yan Yang, Kun Dong. Gender Difference in Liver Enzymes in Newly Defined Subgroups of Diabetes Revealed by a Data-Driven Cluster Analysis. Experimental and Clinical Endocrinology & Diabetes 2022; 130(11): 758 doi: 10.1055/a-1799-8173
|
| 10 |
Xin Wang, Jing Ke, Ying-jun Zhu, Bin Cao, Rui-li Yin, Yan Wang, Ling-ling Wei, Li-jie Zhang, Long-yan Yang, Dong Zhao. Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. Cell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00625-7
|
| 11 |
Yi-Wen Huang, Ting-Chuan Wang, Shih-Chang Lin, Han-Yu Chang, Ding-Shinn Chen, Jui-Ting Hu, Sien-Sing Yang, Jia-Horng Kao. Increased Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients With Newly Diagnosed Diabetes: A Nationwide Cohort Study. Clinical Infectious Diseases 2013; 57(12): 1695 doi: 10.1093/cid/cit603
|
| 12 |
Chia‐Chi Wang, Tai‐Chung Tseng, Jia‐Horng Kao. Hepatitis B virus infection and metabolic syndrome: Fact or fiction?. Journal of Gastroenterology and Hepatology 2015; 30(1): 14 doi: 10.1111/jgh.12700
|
| 13 |
Cong Zhang, Caiyun Sun, Bin Wang, Peipei Yan, Amin Wu, Guokun Yang, Wensheng Li. Orexin-A stimulates the expression of GLUT4 in a glucose dependent manner in the liver of orange-spotted grouper ( Epinephelus coioides ). Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology 2016; 199: 95 doi: 10.1016/j.cbpa.2016.05.027
|
| 14 |
Taylor W. Cook, Amy M. Wilstermann, Jackson T. Mitchell, Nicholas E. Arnold, Surender Rajasekaran, Caleb P. Bupp, Jeremy W. Prokop. Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics. Biomolecules 2023; 13(2): 257 doi: 10.3390/biom13020257
|
| 15 |
L.-N. Xu, L.-H. Yin, Y. Jin, Y. Qi, X. Han, Y.-W. Xu, K.-X. Liu, Y.-Y. Zhao, J.-Y. Peng. Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes. Phytomedicine 2020; 67: 153139 doi: 10.1016/j.phymed.2019.153139
|
| 16 |
Ping-Hsin Hsieh, Jing-Yang Huang, Oswald Ndi Nfor, Chia-Chi Lung, Chien-Chang Ho, Yung-Po Liaw. Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study. Oncotarget 2017; 8(46): 81321 doi: 10.18632/oncotarget.18466
|
| 17 |
Yange Wei, Haixia Yang, Chenhui Zhu, Jianjun Deng, Daidi Fan. Hypoglycemic Effect of Ginsenoside Rg5 Mediated Partly by Modulating Gut Microbiota Dysbiosis in Diabetic db/db Mice. Journal of Agricultural and Food Chemistry 2020; 68(18): 5107 doi: 10.1021/acs.jafc.0c00605
|
| 18 |
André J. Scheen. Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus. Clinical Pharmacokinetics 2014; 53(9): 773 doi: 10.1007/s40262-014-0157-y
|
| 19 |
F. Rajas, P. Labrune, G. Mithieux. Glycogen storage disease type 1 and diabetes: Learning by comparing and contrasting the two disorders. Diabetes & Metabolism 2013; 39(5): 377 doi: 10.1016/j.diabet.2013.03.002
|
| 20 |
Fei Lan, Hirofumi Misu, Keita Chikamoto, Hiroaki Takayama, Akihiro Kikuchi, Kensuke Mohri, Noboru Takata, Hiroto Hayashi, Naoto Matsuzawa-Nagata, Yumie Takeshita, Hiroyo Noda, Yukako Matsumoto, Tsuguhito Ota, Toru Nagano, Masatoshi Nakagen, Ken-ichi Miyamoto, Kanako Takatsuki, Toru Seo, Kaito Iwayama, Kunpei Tokuyama, Seiichi Matsugo, Hong Tang, Yoshiro Saito, Satoshi Yamagoe, Shuichi Kaneko, Toshinari Takamura. LECT2 Functions as a Hepatokine That Links Obesity to Skeletal Muscle Insulin Resistance. Diabetes 2014; 63(5): 1649 doi: 10.2337/db13-0728
|
| 21 |
Michael Leutner, Christian Göbl, Oliver Schlager, Silvia Charwat-Resl, Alice Wielandner, Eleonora Howorka, Marlies Prünner, Latife Bozkurt, Katharina Maruszczak, Hacer Geyik, Helmut Prosch, Giovanni Pacini, Alexandra Kautzky-Willer. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients. Journal of the American College of Nutrition 2017; 36(4): 287 doi: 10.1080/07315724.2016.1262802
|
| 22 |
John Marcinak, Majid Vakilynejad, Akifumi Kogame, Yoshihiko Tagawa. Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment. Drugs in R&D 2018; 18(2): 109 doi: 10.1007/s40268-018-0229-9
|
| 23 |
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surgery Today 2017; 47(6): 733 doi: 10.1007/s00595-016-1444-z
|
| 24 |
Alper Sonmez, Teoman Dogru, Cemal Nuri Ercin, Halil Genc, Gurkan Celebi, Hasan Gurel, Serkan Tapan, Ali Fuat Cicek, Cem Barcin, Cem Haymana, Ali Kirik, Manfredi Rizzo. Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(7): 425 doi: 10.3390/metabo11070425
|
| 25 |
Ting Cai, Tingting Yue, Ming Xu, Pan Zhang, Yue Wang, Qi Liu, Jie Huang, Ting Shen, Qiang Yin, Zhifeng Sheng, Yang Xiao, Tuo Deng, Min Zhang, Erik De Clercq, Chi Zhang, Guangdi Li. Poor glycemic control in type‐2 diabetic patients infected with hepatitis B: A retrospective propensity‐matched study. Journal of Medical Virology 2023; 95(3) doi: 10.1002/jmv.28635
|
| 26 |
Xiu-Ping Bai, Yong-Mei Fan, Lei Zhang, Guo-Hua Yang, Xing Li. Influence of Liver Cirrhosis on Blood Glucose, Insulin Sensitivity and Islet Function in Mice. The American Journal of the Medical Sciences 2021; 362(4): 403 doi: 10.1016/j.amjms.2021.07.005
|
| 27 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
|
| 28 |
Lindokuhle Patience Mabuza, Mlindeli Wilkinson Gamede, Sanam Maikoo, Irvin Noel Booysen, Phikelelani Siphosethu Nguban, Andile Khathi. Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes. Current Therapeutic Research 2019; 91: 66 doi: 10.1016/j.curtheres.2019.100570
|
| 29 |
Zobair Younossi, Katrin Kochems, Marc de Ridder, Desmond Curran, Eveline M. Bunge, Laurence de Moerlooze. Should adults with diabetes mellitus be vaccinated against hepatitis B virus? A systematic review of diabetes mellitus and the progression of hepatitis B disease. Human Vaccines & Immunotherapeutics 2017; 13(11): 2695 doi: 10.1080/21645515.2017.1353850
|
| 30 |
Javier Ampuero, Manuel Romero-Gómez. Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular. Gastroenterología y Hepatología 2012; 35(8): 585 doi: 10.1016/j.gastrohep.2012.02.005
|
| 31 |
Roaid Khan, Graham R. Foster, Tahseen A. Chowdhury. Managing Diabetes in Patients with Chronic Liver Disease. Postgraduate Medicine 2012; 124(4): 130 doi: 10.3810/pgm.2012.07.2574
|
| 32 |
Joo-Won Park, Woo-Jae Park, Yael Kuperman, Sigalit Boura-Halfon, Yael Pewzner-Jung, Anthony H. Futerman. Ablation of very long acyl chain sphingolipids causes hepatic insulin resistance in mice due to altered detergent-resistant membranes. Hepatology 2013; 57(2): 525 doi: 10.1002/hep.26015
|
| 33 |
Carlo B. Giorda, Elisa Nada, Barbara Tartaglino. Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature. Endocrine 2014; 46(3): 406 doi: 10.1007/s12020-014-0179-0
|
| 34 |
André J Scheen. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. Expert Opinion on Drug Metabolism & Toxicology 2014; 10(6): 839 doi: 10.1517/17425255.2014.902444
|
| 35 |
Tae Woo Jung, Yoon Hee Chung, Hyoung-Chun Kim, A.M. Abd El-Aty, Ji Hoon Jeong. Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle. Molecular and Cellular Endocrinology 2018; 470: 26 doi: 10.1016/j.mce.2017.10.014
|
| 36 |
Mina Bakhshaeshi, Arash Khaki, Fatemeh Fathiazad, Amir Afshin Khaki, Elham Ghadamkheir. Anti–oxidative role of quercetin derived from Allium cepa on aldehyde oxidase (OX–LDL) and hepatocytes apoptosis in streptozotocin–induced diabetic rat. Asian Pacific Journal of Tropical Biomedicine 2012; 2(7): 528 doi: 10.1016/S2221-1691(12)60090-2
|
| 37 |
Hirofumi Misu. Pathophysiological significance of hepatokine overproduction in type 2 diabetes. Diabetology International 2018; 9(4): 224 doi: 10.1007/s13340-018-0368-9
|
| 38 |
Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, Asif Ali Burney. Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study. Journal of Diabetes Research 2013; 2013: 1 doi: 10.1155/2013/539361
|
| 39 |
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients. European Journal of Gastroenterology & Hepatology 2018; 30(2): 201 doi: 10.1097/MEG.0000000000001008
|
| 40 |
Simona Alexandra Iacob, Diana Gabriela Iacob. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.814209
|
| 41 |
Chang-Hai Liu, Wei Jiang, Dong-Bo Wu, Qing-Min Zeng, You-Juan Wang, Hong Tang. Concomitant Diseases and Co-contribution on Progression of Liver Stiffness in Patients with Hepatitis B Virus Infection. Digestive Diseases and Sciences 2023; 68(4): 1605 doi: 10.1007/s10620-022-07695-2
|
| 42 |
Yi Shen, Sheng Zhang, Xulin Wang, Yuanyuan Wang, Jian Zhang, Gang Qin, Wenchao Li, Kun Ding, Lei Zhang, Feng Liang. Comparison of type 2 diabetes mellitus incidence in different phases of hepatitis B virus infection: A meta‐analysis. Liver International 2017; 37(10): 1451 doi: 10.1111/liv.13275
|
| 43 |
Yi-Wen Huang, Sien-Sing Yang, Szu-Chieh Fu, Ting-Chuan Wang, Cheng-Kai Hsu, Ding-Shinn Chen, Jui-Ting Hu, Jia-Horng Kao. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: A nationwide cohort study. Hepatology 2014; 60(3): 807 doi: 10.1002/hep.27212
|
| 44 |
Jialin Zheng, Heng Li, Xiaojuan Zhang, Min Jiang, Chunqin Luo, Zhenming Lu, Zhenghong Xu, Jinsong Shi. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota. Journal of Agricultural and Food Chemistry 2018; 66(23): 5821 doi: 10.1021/acs.jafc.8b00829
|